Table 1.
Variables | n | KGFR
|
KGF
|
KGFR and KGF
|
|||
---|---|---|---|---|---|---|---|
n (%) | P | n (%) | P | n (%) | P | ||
Gender | |||||||
Male | 36 | 17 (47) | NS | 12 (33) | NS | 9 (25) | NS |
Female | 17 | 5 (29) | 6 (35) | 4 (24) | |||
Age | |||||||
<65 | 24 | 8 (33) | NS | 7 (29) | NS | 3 (13) | NS |
65+ | 29 | 14 (48) | 11 (38) | 10 (34) | |||
UICC classification | |||||||
T-primary tumor | |||||||
T1 | 3 | 2 (67) | NS | 1 (33) | NS | 1 (33) | NS |
T2 | 3 | 1 (33) | 1 (33) | 1 (33) | |||
T3 | 15 | 7 (47) | 8 (53) | 5 (33) | |||
T4 | 32 | 12 (36) | 8 (25) | 6 (19) | |||
N-Regional lymph nodes | |||||||
N0 | 19 | 11 (58) | NS | 8 (42) | NS | 6 (32) | NS |
N1 | 34 | 11 (32) | 10 (29) | 7 (21) | |||
M-Distant metastasis | |||||||
M0 | 51 | 21 (41) | NS | 17 (33) | NS | 12 (24) | NS |
M1 | 2 | 1 (50) | 1 (50) | 1 (50) | |||
G-Histological grading | |||||||
G1 | 31 | 14 (45) | NS | 8 (26) | NS | 6 (19) | NS |
G2 | 21 | 7 (33) | 9 (43) | 6 (29) | |||
G3 | 1 | 1 (100) | 1 (100) | 1 (100) | |||
G4 | 0 | 0 | 0 | 0 | |||
Stage | |||||||
I or II | 10 | 5 (50) | NS | 1 (10) | NS | 4 (40) | NS |
III or IV | 43 | 17 (40) | 17 (40) | 9 (21) | |||
Other tumor characteristics | |||||||
Lymphatic invasion | |||||||
Negative | 6 | 3 (50) | NS | 2 (33) | NS | 2 (33) | NS |
Positive | 47 | 19 (40) | 16 (34) | 11 (23) | |||
Venous invasion | |||||||
Negative | 35 | 11 (31) | 0.038 | 8 (23) | 0.017 | 5 (14) | 0.016 |
Positive | 18 | 11 (61) | 10 (56) | 8 (44) | |||
Nerve invasion (intrapancreatic) | |||||||
Negative | 11 | 6 (55) | NS | 5 (45) | NS | 3 (27) | NS |
Positive | 42 | 16 (38) | 13 (31) | 10 (24) |
UICC, International Union Against Cancer; NS, not significant.